Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Plx Pharma Inc. (DPRX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Plx Pharma Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1497504.
Total stock buying since 2014: $2,574,082.
Total stock sales since 2014: $0.
Total stock option exercises since 2014: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 17,800 | $65,077 | 0 | $0 | 0 | $0 |
| 2021 | 33,000 | $299,760 | 0 | $0 | 0 | $0 |
| 2020 | 279,370 | $1,061,089 | 0 | $0 | 0 | $0 |
| 2019 | 44,404 | $248,662 | 0 | $0 | 0 | $0 |
| 2018 | 397,495 | $397,495 | 0 | $0 | 0 | $0 |
| 2017 | 69,091 | $474,999 | 0 | $0 | 0 | $0 |
| 2014 | 3,000 | $27,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-03 | 17,800 | $65,077 | 0 | $0 | 0 | $0 |
| 2021-06 | 8,000 | $99,760 | 0 | $0 | 0 | $0 |
| 2021-03 | 25,000 | $200,000 | 0 | $0 | 0 | $0 |
| 2020-12 | 1,000 | $5,455 | 0 | $0 | 0 | $0 |
| 2020-11 | 265,400 | $1,005,914 | 0 | $0 | 0 | $0 |
| 2020-09 | 6,620 | $24,964 | 0 | $0 | 0 | $0 |
| 2020-08 | 6,350 | $24,756 | 0 | $0 | 0 | $0 |
| 2019-05 | 44,404 | $248,662 | 0 | $0 | 0 | $0 |
| 2018-12 | 397,495 | $397,495 | 0 | $0 | 0 | $0 |
| 2017-06 | 69,091 | $474,999 | 0 | $0 | 0 | $0 |
| 2014-05 | 3,000 | $27,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-03-15 | O'connor Rita M (Chief Financial Officer) | Buy | 13,700 | 3.66 | 50,100 |
| 2022-03-15 | Giordano Natasha (Chief Executive Officer) | Buy | 4,100 | 3.65 | 14,977 |
| 2021-06-14 | Valentino Michael J (Executive Chairman) | Buy | 8,000 | 12.47 | 99,760 |
| 2021-03-05 | Valentino Michael J (Executive Chairman) | Buy | 25,000 | 8.00 | 200,000 |
| 2020-12-14 | Hadden John | Buy | 1,000 | 5.46 | 5,455 |
| 2020-11-25 | Hadden John | Buy | 500 | 5.48 | 2,738 |
| 2020-11-18 | Valentino Michael J (Executive Chairman) | Buy | 264,900 | 3.79 | 1,003,176 |
| 2020-09-02 | O'connor Rita M (Chief Financial Officer) | Buy | 2,120 | 3.83 | 8,125 |
| 2020-09-01 | O'connor Rita M (Chief Financial Officer) | Buy | 4,500 | 3.74 | 16,839 |
| 2020-08-21 | O'connor Rita M (Chief Financial Officer) | Buy | 4,050 | 3.97 | 16,090 |
| 2020-08-20 | O'connor Rita M (Chief Financial Officer) | Buy | 2,300 | 3.77 | 8,666 |
| 2019-05-20 | Valentino Michael J (Executive Chairman) | Buy | 44,404 | 5.60 | 248,662 |
| 2018-12-27 | Park West Asset Management Llc | Buy | 397,495 | 1.00 | 397,495 |
| 2017-06-14 | Valentino Michael J (Executive Chairman) | Buy | 29,091 | 6.88 | 200,000 |
| 2017-06-14 | Jorden David Emerson (Acting Chief Financial Officer) | Buy | 32,727 | 6.88 | 224,998 |
| 2017-06-14 | Mossman Gary L (Chief Operating Officer) | Buy | 7,273 | 6.88 | 50,001 |
| 2014-05-21 | Dean Jack H (Director) | Buy | 3,000 | 9.00 | 27,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of DPRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Plx Pharma Inc. (symbol DPRX, CIK number 1497504) see the Securities and Exchange Commission (SEC) website.